Translational Genomics Research Institute

Research institute

This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (March 2020) (Learn how and when to remove this message)

|

33°27′10.68″N 112°4′1.83″W﻿ / ﻿33.4529667°N 112.0671750°W﻿ / 33.4529667; -112.0671750

Translational Genomics Research InstituteCompany type| Research Institute

|

Industry| Genomics
Founded| July 2002, Phoenix, Arizona, United States
Headquarters| Phoenix, Arizona, United States

Key people

| Jeffrey Trent[1]
Revenue|

* $51.7 million (2007)[2]
* $18.3 million (2003)[2]

Total assets| 24,398,471 United States dollar (2022)

Number of employees

| 258 (2008)[2]
Website| www.tgen.org
The Translational Genomics Research Institute at night

The Translational Genomics Research Institute (TGen) is a non-profit genomics research institute based in Phoenix, Arizona, United States.

## History and activities

[edit]

TGen was established in July 2002 by Jeffrey Trent in Phoenix, Arizona, with an initial investment of US$100 million from Arizona public- and private-sector investors.[2]

The field of translational genomics research searches for ways to apply results from the Human Genome Project to the development of improved diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes and other complex diseases.

The mission of TGen is to make and translate genomic discoveries into advances in human health.[3] TGen has contributed to the growth of scientific research and biotechnology in Arizona. The institute has been involved in collaborations and studies, such as the research on chronic traumatic encephalopathy (CTE) in former NFL players in partnership with Exosome Sciences.[4]

## References

[edit]

1. ^ "Administrative leadership". Tgen. Retrieved April 8, 2024.
2. ^ a b c d Alltucker, Ken (16 April 2008). "5-year-old TGen fights for funding". The Arizona Republic. Archived from the original on 17 January 2013.
3. ^ Alltucker, Ken (16 April 2008). "Cancer-drug trials show promise". The Arizona Republic. Archived from the original on 17 January 2013.
4. ^ "Exosome Sciences, TGen to Launch Study of CTE in Former NFL Players". CellOMICs. 26 March 2018. Retrieved 27 March 2018.

Authority control databases |

* ISNI

|